Transfusion Surveillance in Anaesthesia
Launched by ERASME UNIVERSITY HOSPITAL · May 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Transfusion Surveillance in Anaesthesia," is designed to study how blood transfusions are handled during emergency situations, particularly when a patient is experiencing heavy bleeding. The goal is to gather detailed information about what happens during these transfusions so that doctors can better understand and improve care for patients who need blood products in critical situations.
If you or a loved one has received a blood product to help stop bleeding, you might be eligible to participate in this study. The trial is open to all patients, regardless of age or gender, as long as they consent to share their data. Participants can expect to be part of a research effort that collects important information to help improve the safety and effectiveness of blood transfusions during emergencies. It's important to know that if someone chooses not to participate or does not agree to allow their data to be used, they will not be included in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients who have received an hemostasis product
- Exclusion Criteria:
- • patient who refused to consent to data analysis and study participation
About Erasme University Hospital
Erasme University Hospital, a leading institution in clinical research and patient care, is dedicated to advancing medical knowledge and improving health outcomes through innovative clinical trials. As a prominent academic hospital affiliated with the Université libre de Bruxelles, it combines cutting-edge research with comprehensive clinical services, fostering collaboration among healthcare professionals, researchers, and patients. With a strong emphasis on rigorous scientific methodologies and ethical standards, Erasme University Hospital aims to contribute to the development of new therapies and treatment protocols that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anderlecht, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported